Ann Marie Thrailkill, NP
Family · Palo Alto
- Medicare standing
- 1 flag on the record
- Listed below.
- Plans that list them
- Not verified
- Not the same as out of network.
- Office
- 1
On the public record
- Medicare does not list them as allowed to order and refer
Offices
1 location
Plan participation
Not verified
We could not verify current plan participation for this doctor. This does not mean they are out of network. Call Ann Marie Thrailkill’s office at (650) 493-5000 to ask if they take your plan before you enroll.
Money from drug and device companies
$1,002 in 2025
| 2025 | 7 | 8 | None | $1,002 |
| 2024 | 11 | 13 | None | $1,518 |
| 2023 | 7 | 9 | None | $991 |
| 2022 | 4 | 4 | None | $453 |
| 2021 | 2 | 3 | None | $244 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Madrigal Pharmaceuticals | Rezdiffra | $262 | 2 payments
|
| Galderma Laboratories L.P. | Nemluvio | $140 | 1 payment
|
| Edwards Lifesciences | Sapien 3 Ultra Resilia | $137 | 1 payment
|
| Gilead Sciences | None | $127 | 1 payment
|
| Argenx US | Vyvgart | $115 | 1 payment
|
| Otsuka Pharmaceutical Development & Commercialization | None | $112 | 1 payment
|
See all 8 published payments
| Argenx US | Meals · 2025-11-11 | Vyvgart | $115 |
| Madrigal Pharmaceuticals | Meals · 2025-10-16 | Rezdiffra | $137 |
| Gilead Sciences | Meals · 2025-09-17 | None | $127 |
| Janssen Pharmaceuticals | Meals · 2025-06-27 | Spravato | $109 |
| Galderma Laboratories L.P. | Meals · 2025-05-13 | Nemluvio | $140 |
| Madrigal Pharmaceuticals | Meals · 2025-04-17 | Rezdiffra | $125 |
| Edwards Lifesciences | Meals · 2025-03-28 | Sapien 3 Ultra Resilia | $137 |
| Otsuka Pharmaceutical Development & Commercialization | Meals · 2025-03-13 | None | $112 |
See earlier years (2024, 2023, 2022, 2021)
2024: $1,518
| Gilead Sciences | Epclusa | $367 | 3 payments
|
| Ipsen Biopharmaceuticals | Iqirvo | $143 | 1 payment
|
| Neurocrine Biosciences | Ingrezza | $136 | 1 payment
|
| Genzyme | Dupixent | $125 | 1 payment
|
| Otsuka America Pharmaceutical | Jynarque | $122 | 1 payment
|
| Otsuka Pharmaceutical Development & Commercialization | None | $122 | 1 payment
|
| Si-Bone | None | $112 | 1 payment
|
| Sage Therapeutics | None | $107 | 1 payment
|
| Hologic Sales and Service | Aptima | $105 | 1 payment
|
| Biogen | Spinraza | $93 | 1 payment
|
| Boehringer Ingelheim Pharmaceuticals | Jardiance | $87 | 1 payment
|
2023: $991
| Abbvie | Vraylar | $236 | 2 payments
|
| Intercept Pharmaceuticals | Ocaliva | $181 | 2 payments
|
| Gilead Sciences | Epclusa | $125 | 1 payment
|
| Otsuka Pharmaceutical Development & Commercialization | Jynarque | $125 | 1 payment
|
| Mayne Pharma Commercial | Nextstellis | $124 | 1 payment
|
| Salix Pharmaceuticals a division of Bausch Health US | Xifaxan | $106 | 1 payment
|
| Biogen | None | $94 | 1 payment
|
2022: $453
| Vertos Medical | Mild Device Kit | $128 | 1 payment
|
| Abbvie | Vraylar | $125 | 1 payment
|
| Eisai | None | $108 | 1 payment
|
| Lilly USA | Emgality | $92 | 1 payment
|
2021: $244
| Biohaven Pharmaceuticals | Nurtec Odt | $152 | 2 payments
|
| AbbVie | Ubrelvy | $92 | 1 payment
|
Professional record
- NPI
- 1689635963
- Licence
- CA 394356
More record details
- Sole proprietor
- No
- Taxonomy
- Federal specialty code 363LF0000X (363LF0000X)
- Mailing address
- 101 1st St, Suite 205, Los Altos, CA, 94022
- NPI first listed
- 2006-03-28
- NPI last updated
- 2014-11-13
This is when the NPI record was last certified, not a medical board exam.